| 1 |
2024.08.12__DR_S.O. 3266(E) to 3267(E)_ Restriction of FDC (Naproxen + Esomeprazole and Naproxen + Pantoprazole) |
2024-Aug-12 |
|
1816 KB |
| 2 |
2024.08.12__DR_S.O. 3285(E) to 3440(E)_ Prohibition of 156 FDCs |
2024-Aug-12 |
|
3234 KB |
| 3 |
2024.08.12_S.O. 3284(E)_Notification reg Prohibiton of Etodolac |
2024-Aug-12 |
|
1690 KB |
| 4 |
2024.07.12_DR_G.S.R. 391(E)_Inclusion of details of excipient on every strip of medicines under Rule 96, in sub-rule (7) of Drugs Rules, 1945 |
2024-Jul-12 |
|
1677 KB |
| 5 |
2024.07.10_DR_G.S.R. 375(E)_Notification for No Advertisements of Drugs Specified in Schedule G under Drugs Rules, 1945 |
2024-Jul-10 |
|
1703 KB |
| 6 |
2024.07.10_DR_G.S.R.374(E)_Notification reg rules for Compounding of offences under D & C Act |
2024-Jul-10 |
|
1746 KB |
| 7 |
2024.05.28 DR G.S.R. 293 E Inclusion of Cochin and Thiruvananthapuram Ports in Rule 43A of Drugs Rules, 1945 |
2024-May-28 |
|
717 KB |
| 8 |
2024.03.28_S.O. 1577(E)_implementation of Jan Vishwas (Amendment of Provisions) Act, 2023 related to Provisions of D & C Act |
2024-Mar-28 |
|
799 KB |
| 9 |
2024.03.18_DR_G.S.R. 216(E)_Omission of Glyceryl Trinitrate and Isosorbide Dinitrate from Schedule P1 and modification in Rule 105 |
2024-Mar-18 |
|
1249 KB |
| 10 |
2024.02.27_DR_G.S.R. 139(E)_Notification of Bengaluru, Visakhapatnam, Cochin and Thiruvananthapuram Air Ports |
2024-Feb-27 |
|
1099 KB |
| 11 |
2024.02.06_S.O. 567(E)_Notification of Government Analysts for CDTL Indore |
2024-Feb-06 |
|
1141 KB |
| 12 |
2024.02.05 S.O. 476(E) Revoke of notification GSR 144(E) dated 17.02.2017 Oseltamivir and Zanamivir |
2024-Feb-05 |
|
908 KB |
| 13 |
2024.02.05_DR_G.S.R. 95(E)_Inclusion of Oseltamivir and Zanamivir in Schedule H1 |
2024-Feb-05 |
|
1158 KB |
| 14 |
2024.02.02_DR_G.S.R. 91(E)_ Notification of Government Analysts for NIB Noida |
2024-Feb-02 |
|
1046 KB |
| 15 |
2023.12.28_DR_Final G.S.R. 922(E)_Notification of Schedule M of Drugs Rules,1945. |
2023-Dec-28 |
|
3272 KB |
| 16 |
2023.11.07_S.O. 4834(E)_In compliance to the Jan Vishwas (Amendment of Provisions) Act, 2023 |
2023-Nov-07 |
|
657 KB |
| 17 |
2023.10.05 S.O. 4351(E) Notification of Government Analyst CDTL MUMBAI |
2023-Oct-05 |
|
883 KB |
| 18 |
DR_ Draft_G.S.R. 686 (E) dt_25.09.2023_Inclusion of Oseltamivir and Zanamivir in Schedule H1 |
2023-Sep-25 |
|
658 KB |
| 19 |
DR_Draft_G.S.R. 687(E) dt_25.09.2023_Omission of Glyceryl Trinitrate and Isosorbide Dinitrate from Schedule P1 and modification in Rule 105 |
2023-Sep-25 |
|
1310 KB |
| 20 |
2023.07.31_DR_S.O. 3448(E)_Prohibition of Veterinary Drugs Ketoprofen and its formulation and Aceclofenac its Formulation |
2023-Jul-31 |
|
1085 KB |
| 21 |
2023.06.02_DR_ G.S.R 410(E)_Notification of Gangavaram Port |
2023-Jun-02 |
|
1130 KB |
| 22 |
02.06. 2023 G.S.R 409(E) Medical Devices |
2023-Jun-02 |
|
1157 KB |
| 23 |
2023.06.02_DR_S.O. 2394(E) to 2407(E)_Banning of 14 FDCs |
2023-Jun-02 |
|
1209 KB |
| 24 |
2023.05.15_CR_Draft G.S.R. 371(E)_Certain amendments in Cosmetics Rule 2020 |
2023-May-15 |
|
1173 KB |
| 25 |
2023.05.15_S.O. 2191(E)_NIB Government Analyst Notification |
2023-May-15 |
|
603 KB |
| 26 |
2023.05.11_Draft_NDCTR_G.S.R. 364(E)_Notification for registration of Clinical Research Organisation (CRO) |
2023-May-11 |
|
1203 KB |
| 27 |
2023.05.11_DR_S.O. 2177(E) _Government Analyst Notification at CDL, Kolkata |
2023-May-11 |
|
618 KB |
| 28 |
S.O. 1928(E)_25.04.2023_Notification for testing Covid kit NIB Noida |
2023-Apr-25 |
|
567 KB |
| 29 |
2023.03.09_NDCTR_G.S.R. 175(E)_ Amendment in First Schedule regarding use of induced Pluripotent Stem Cells additional testing methods |
2023-Mar-09 |
|
605 KB |
| 30 |
2023.03.01_MDR_Draft_ GSR 157(E)_Medical Device Rule 18 and 19 Amendment (Central Government and State Government) |
2023-Mar-01 |
|
642 KB |
| 31 |
2023.03.01_DR_Draft_GSR 158(E)_Notification of Gangavaram port |
2023-Mar-01 |
|
569 KB |
| 32 |
2023.02.08_S.O. 627(E)_Government Analyst Notification at CDTL Hyderabad |
2023-Feb-08 |
|
1317 KB |
| 33 |
NDCTR_G.S.R. 835(E) dt_22.11.2022_Amendment in First Schedule for non clinical testing methods for new drugs (Pluripotent) |
2022-Nov-22 |
|
1245 KB |
| 34 |
2022.11.17_Final GSR 823(E)_Amendment in rule 96 for mandating Bar or QR code on the label of top 300 brand in Drugs Rules |
2022-Nov-17 |
|
1363 KB |
| 35 |
2022.11.02_S.O. 5090(E)_Notification of eligible officers at CDTL Chennai as Govt Analyst under section 20 of the Drugs and Cosmetics Act 1940 |
2022-Nov-02 |
|
1357 KB |
| 36 |
MDR_G.S.R. 777(E) dt_14.10.2022_exemption of non sterile and non measuring Class A medical devices from licensing regime |
2022-Oct-14 |
|
1102 KB |
| 37 |
2022.10.14_Final GSR 778(E)_Insertion of Provisions for deemed approvals in various rules under NDCTR 2019 |
2022-Oct-14 |
|
1209 KB |
| 38 |
G.S.R 778 (E) dated 14 Oct 2022 regarding the New Drugs and Clinical Trials (Third Amendment) Rules 2022 |
2022-Oct-14 |
|
1209 KB |
| 39 |
G.S.R. 777(E) 14 Oct 2022 Final notification for exemption of non sterile and non measuring Class A medical devices from licensing regime |
2022-Oct-14 |
|
1020 KB |
| 40 |
GSR 754 (E) 30-09-2022 sale of medical device retail and wholesale |
2022-Sep-30 |
|
1348 KB |
| 41 |
2022.09.28_S.O. 4574(E)_Designation of Government Analysts at RDTL Chandigarh as MDTO as per MDR 2017 |
2022-Sep-28 |
|
1220 KB |
| 42 |
2022.09.28_S.O._4573(E)_Notification for designation of RDTL Chandigarh also as CMDTL as per MDR 2017 |
2022-Sep-28 |
|
1291 KB |
| 43 |
2022.09.20_Draft_GSR 710(E)_Exemption of certain Class A medical device from licensing regime |
2022-Sep-20 |
|
1300 KB |
| 44 |
2022.08.24_Final GSR 654(E)_Parallel submission in Form 28-D |
2022-Aug-24 |
|
1242 KB |
| 45 |
2022.08.10_Final GSR 623(E)_To include colour of disinfectants in rule 127 of Drugs Rules 1945. |
2022-Aug-10 |
|
1033 KB |
| 46 |
2022.08.10_S.O. 3757(E)_Notification of Director Incharge of CDL Kolkata |
2022-Aug-10 |
|
1454 KB |
| 47 |
2022.08.10_S.O. 3758(E)_To authorize director incharge of CDL Kolkata for signing report of test of MD samples sent by Court of MD samples sent by Court of Laws. |
2022-Aug-10 |
|
766 KB |
| 48 |
Extract of the New Drugs and Clinical Trials Rules 2019 relevant to Ethics Committee for Clinical Trial, Bioavailability and Bioequivalence study |
2022-Aug-08 |
|
354 KB |
| 49 |
2022.08.02_S.O. 3739(E)_Notification of Medical Devices Testing Officer for CMDTL |
2022-Aug-02 |
|
1126 KB |
| 50 |
2022.06.30_Final GSR 502(E)_Proviso to Sr.no 39 in Sch K for Liquid Antiseptics in Drugs Rules |
2022-Jun-30 |
|
1289 KB |
| 51 |
2022.06.15_Final GSR 450(E)_To amend Fourth Schedule wrt TSE or BSE certificate under MDR |
2022-Jun-15 |
|
1348 KB |
| 52 |
22.06.14_Draft_GSR 448(E)_Amendment in rule 96 for mandating Bar code or QR code on the label of top 300 brand in Drugs Rules |
2022-Jun-14 |
|
1484 KB |
| 53 |
2022.05.25_Draft_GSR 393(E)_Exemption under Schedule K of the Drugs Rules, 1945 for OTC drugs |
2022-May-25 |
|
1504 KB |
| 54 |
2022.05.23_Draft GSR 383(E)_Proviso to Sr.no 39 in Sch K for Liquid Antiseptics in Drugs Rules |
2022-May-23 |
|
1145 KB |
| 55 |
2022.05.23_Draft GSR 382(E)_Parallel submission in Form 28-D |
2022-May-23 |
|
1149 KB |
| 56 |
2022.05.18_Final GSR 356(E)_Insert rule 43A for Suspension and cancellation of license in MDR 2017 |
2022-May-18 |
|
1137 KB |
| 57 |
2022.05.18_Final GSR 357(E)_Inclusion of Acitretin in Sch H of Drugs Rules 1945 |
2022-May-18 |
|
1314 KB |
| 58 |
2022.03.29_Draft GSR 228(E)_To amend Fourth Schedule wrt TSE or BSE certificate under MDR |
2022-Mar-29 |
|
1427 KB |
| 59 |
2022.03.29_Draft GSR 227(E)_To include colour of disinfectants in rule 127 of Drugs Rules 1945 |
2022-Mar-29 |
|
1572 KB |
| 60 |
2022.03.04_Final GSR 174(E)_Amendment of rule 36(3) MDR to include United Kingdom under MDR,2017 |
2022-Mar-04 |
|
1250 KB |
| 61 |
2022.02.24_Final GSR 158(E)_Inclusion of allura red colour in rule 127 of the Drugs Rules 1945 |
2022-Feb-24 |
|
1423 KB |
| 62 |
2022.02.24_Final GSR 158_Inclusion of allura red colour in rule 127 of the Drugs Rules 1945 |
2022-Feb-24 |
|
1423 KB |
| 63 |
2022.02.09_S.O. 553(E)_ Stockpiling of new drug under phase 3 of clinical trial_NDCTR,2019 |
2022-Feb-09 |
|
1106 KB |
| 64 |
2022.02.09_Draft GSR 104(E)_Regulation of sale of medical devices via registration of premises under MDR, 2017 |
2022-Feb-09 |
|
1520 KB |
| 65 |
2022.02.01_ Draft GSR 75(E)_Inclusion of Acitretin in Sch H of Drugs Rules 1945 |
2022-Feb-01 |
|
1364 KB |
| 66 |
2022.01.21_Draft_GSR 32(E)_Insertion of Provisions for deemed approvals in various rules under NDCTR 2019 |
2022-Jan-21 |
|
1483 KB |
| 67 |
2022.01.20_Final GSR 30(E)_Amendment of Sch K for Liquid Antiseptics at Sr. no 39 in Drugs Rules |
2022-Jan-20 |
|
1375 KB |
| 68 |
2022.01.18_Draft GSR 23(E)_Insert rule 43A for Suspension and cancellation of license in MDR 2017 |
2022-Jan-18 |
|
1363 KB |
| 69 |
2022.01.18_Final GSR 19(E)_Amendment in rules 19B, 19C,19D &19E of MDR 2017 |
2022-Jan-18 |
|
1557 KB |
| 70 |
2022.01.18_Final GSR 20(E)_QR code for active pharmaceutical ingredients |
2022-Jan-18 |
|
1549 KB |
| 71 |
2022.01.18_Final GSR 21(E)_Amendment in Eighth Schedule, Form CT-03 |
2022-Jan-18 |
|
1361 KB |
| 72 |
2022.01.13_Final GSR 14(E)_To amend rule 2 to substitute cell or stem cell derived product under NDCTR 2019 |
2022-Jan-13 |
|
1169 KB |
| 73 |
2021.12.31_Final GSR 918(E)_Amendment of rnule 46 of MDR for Unique Device Identification |
2021-Dec-31 |
|
1335 KB |
| 74 |
2021.12.23_Draft S.O. 877(E)_Amendment of rule 46 of MDR for Unique Device Identificatio |
2021-Dec-23 |
|
1472 KB |
| 75 |
2021.12.10_Draft GSR 850(E)_Amendment of rule 36(3) MDR to include United Kingdom |
2021-Dec-10 |
|
1222 KB |
| 76 |
2021.12.10_S.O. 5139(E)_Renotification of NIB Noida as CDL for testing and lot release of COVID 19 vaccine |
2021-Dec-10 |
|
1337 KB |
| 77 |
2021.12.09_Final_GSR 848(E)_Notification of ICD Tihi,M.P. in rule 43A of Drugs Rules |
2021-Dec-09 |
|
1080 KB |
| 78 |
2021.11.29_GSR 839(E)_ Amendment of rule 24 and 24A of the Drugs Rules, 1945 to omit provisions for issuing duplicate copy of the Import licence and Registration certificate |
2021-Nov-29 |
|
1623 KB |
| 79 |
2021.11.29_ Draft GSR 840(E)_Amendment of rule 127 of the Drugs Rules 1945 for adding allura red in coal tar colour (List of colours permitted to be used in drugs) |
2021-Nov-29 |
|
1608 KB |
| 80 |
2021.10.27_Draft GSR 767(E) to amend rule 2 to substitute cell or stem cell derived product under NDCTR 2019 |
2021-Oct-27 |
|
4213 KB |
| 81 |
2021.10.27_Final GSR 766(E) reg Rule 90,Form 29 deemed approval |
2021-Oct-27 |
|
1173 KB |
| 82 |
2021.10.27_Final GSR 762(E) reg Oxytocin API import exclusivelyfor mfg for export purpose only |
2021-Oct-27 |
|
1274 KB |
| 83 |
2021.10.18_S.O. 4326(E)_Reconstitution of DTAB 2021 |
2021-Oct-18 |
|
1220 KB |
| 84 |
2021.10.12_Draft GSR 729(E)_Amendment in rules 19B, 19C,19D &19E of MDR 2017 |
2021-Oct-12 |
|
1230 KB |
| 85 |
2021.09.13_Draft GSR 628(E)_Amendment of Sch K for Liquid Antiseptics at Sr. no 39 |
2021-Sep-13 |
|
1523 KB |
| 86 |
2021.09.07_Draft GSR 618(E)_Amendment of rule 24 and 24A of Drugs Rules for duplicate copy of licence |
2021-Sep-07 |
|
150 KB |
| 87 |
2021.09.02_S.O. 3596(E)_Notification of Amar Jyoti, Dilip Sarkar, Rinku Kalita & Arun Kr Das as MDTO |
2021-Sep-02 |
|
1585 KB |
| 88 |
2021.09.01_Draft GSR 611(E)_Notification of ICD Tihi Indore under Rule 43A |
2021-Sep-01 |
|
1198 KB |
| 89 |
2021.08.31 Final G.S.R. 605(E) Standalone Bioanalytical laboratory Rule2 NDCTR 2019 |
2021-Aug-31 |
|
1634 KB |
| 90 |
2021.08.17_S.O. 3364(E)_Notification of National Institute of Animal Biotechnology (NIAB), Hyderabad for COVID vaccines |
2021-Aug-17 |
|
1245 KB |
| 91 |
2021.08.03_Draft G.S.R. 533(E)_Rule 90, Form 29 Deemed approval |
2021-Aug-03 |
|
1154 KB |
| 92 |
2021.08.02_Draft GSR 524(E)_Amendment in Eighth Schedule, Form CT-03 |
2021-Aug-02 |
|
1608 KB |
| 93 |
2021.07.22_Draft_GSR 502(E)_Rule 127 to insert IS4707(Part 1) by BIS |
2021-Jul-22 |
|
1160 KB |
| 94 |
2021.06.28_SO 2609(E)_Notification of NCCS Pune for COVID Vaccine testing valid till one year |
2021-Jun-28 |
|
1460 KB |
| 95 |
2021.06.25_SO 2572(E)_Notification of 172 Drugs Inspectors as MDO |
2021-Jun-25 |
|
1485 KB |
| 96 |
2021.06.22_SO 2449(E)_Notification of 14 Govt Analysts for CDTL Mumbai |
2021-Jun-22 |
|
1366 KB |
| 97 |
2021.06.22_SO 2450(E) Notification of Dilip Kr Panda Suparna Maitra as GA for CDL Kolkata |
2021-Jun-22 |
|
1127 KB |
| 98 |
2021.06.22_SO 2451(E)Notification of Sumir Rai Bhalla as GA for CDL Kasauli |
2021-Jun-22 |
|
1160 KB |
| 99 |
2021.04.08_S.O. 1521(E)_Amendment of S.O. 2808(E) dt 30.11.2012 for including three more GA at CDTL Mumbai |
2021-Apr-08 |
|
16252 KB |
| 100 |
2021.04.07_GSR 255(E)_For substitution at entry no 14. of GSR 578(E) dt 23.07.1983 reg FDC of tamsulosin+Deflazacort |
2021-Apr-07 |
|
1501 KB |
| 101 |
2021.04.07_GSR 258(E)_ Inclusion of Tapentadol in Sch H1 at S.No. 48 |
2021-Apr-07 |
|
1225 KB |
| 102 |
2021.04.07_S.O. 1520(E)_Notification of Raghuram Reddy Adidala, CDTL Hyderabad |
2021-Apr-07 |
|
1732 KB |
| 103 |
2021.03.19_S.O.1260(E)_Notification of Debasis Maitti and Hitesh Khare as Govt. Analysts at RDTL Chandigarh |
2021-Mar-19 |
|
1263 KB |
| 104 |
2021.03.12_S.O. 1170(E)_Notifying Amar jyoti, Dilip Kr, Rinku & Arun Kr at RDTL Guwahati as Govt. analyst |
2021-Mar-12 |
|
1452 KB |
| 105 |
2021.02.26_GSR 140(E)_Schedule K at serial number 23 to include Anganwadi worker |
2021-Feb-26 |
|
1369 KB |
| 106 |
2021.02.05_Draft GSR 98(E)_American Standard Test Method (ASTM) in the product standards for Medical Devices under Rule 7 of MDR-2017 |
2021-Feb-05 |
|
114 KB |
| 107 |
2021.02.05_Draft GSR 99(E)_For inclusion of provisions related to the registration of stand alone bio analytical laboratories in the NDCT Rules, 2019 |
2021-Feb-05 |
|
1092 KB |
| 108 |
2021.02.04_S.O. 529(E)_Notification of Dr. Sandeep Singh & Dr. Sweta Raghuvanshi for Scepticemia and Rankhet Vaccines |
2021-Feb-04 |
|
1578 KB |
| 109 |
Gazette notification G.S.R 763(E) dated 15.12.2020_Cosmetics Rules 2020 |
2020-Dec-15 |
|
2819 KB |
| 110 |
2020.11.26_S.O. 4244(E)_Extension of Import license amid COVID-19 Pandemic for 6 months |
2020-Nov-26 |
|
1384 KB |
| 111 |
2020.11.24_S.O. 4206(E)_Notifying of NIB Noida for testing COVID-19 Vaccine |
2020-Nov-24 |
|
1256 KB |
| 112 |
S.O. 3722(E) dated 21.10.202 |
2020-Oct-21 |
|
1215 KB |
| 113 |
2020.10.21_Draft GSR 656(E)_Inclusion of Tapentadol in Sch H1.pdf |
2020-Oct-21 |
|
1153 KB |
| 114 |
S.O. 2451(E)_Exemption of hand sanitizer from sale licence_Section 26B |
2020-Jul-27 |
|
1106 KB |
| 115 |
S.O. 2450(E) Dt. 27.07.2020_Reg. validity of existing Registration Certificate for import of drugs__Section 26B |
2020-Jul-27 |
|
1010 KB |
| 116 |
2020.06.05 Draft GSR 354 E compassionate use of new drug |
2020-Jun-05 |
|
1458 KB |
| 117 |
S.O.1511(E) Dt. 18.05.2020_Regulations for manufacture and stock of vaccines for COVID-19_Section 26B |
2020-May-18 |
|
1120 KB |
| 118 |
GSR 219(E) Dt. 26.03.2020_Sale of Hydroxychloroquine as per Schedule H1_Section 26B |
2020-Mar-26 |
|
1190 KB |
| 119 |
GSR 220(E) Dt. 26.03.2020_Doorstep delivery of the drugs by retail _Section 26B |
2020-Mar-26 |
|
1343 KB |
| 120 |
2020.18.03_ Final G.S.R. 166(E)_Amendment in Part X B & Part XII B pertains to Blood centre and Blood components |
2020-Mar-18 |
|
2041 KB |
| 121 |
2020-16-03_GSR 180 (E) banning of Chenodeoxycholic acid&Ursodeoxycholic acid extracted and prepareunder Section 10A |
2020-Mar-16 |
|
773 KB |
| 122 |
2020.02.13_Final G.S.R. 101(E)_Definition, Responsibility & labelling requirements for marketer of the drugs |
2020-Feb-13 |
|
787 KB |
| 123 |
G.S.R. 102(E)_dated 11.02.2020_ Registration of certain medical devices |
2020-Feb-11 |
|
1192 KB |
| 124 |
S.O. 648(E) dated 11.02.2020_ Medical Device Definition |
2020-Feb-11 |
|
902 KB |
| 125 |
2020.01.31_S.O. 481(E)_Sushil Kumar Sahu GA, CDL Kasauli |
2020-Jan-31 |
|
935 KB |
| 126 |
2020.01.27_G.S.R. 52(E) Exemption of Import of Oxytocin reference standards from Prohibition |
2020-Jan-27 |
|
668 KB |
| 127 |
Gazette Notification S.O. 4672 (E) dated 27 December 2019 |
2019-Dec-27 |
|
254 KB |
| 128 |
2019.12.27 S.O.4671(E)_Extention of Effective date of S.O. 5980 (E) dated 03.12.2018 |
2019-Dec-27 |
|
242 KB |
| 129 |
2019.11.26_S.O. 4271(E)_ Govt. Analyst at NIB Noida |
2019-Nov-26 |
|
368 KB |
| 130 |
2019.11.06_Final G.S.R. 828(E)_Condition of licence for undertaking on brand or trade names of drugs under D & C Rules, 1945 |
2019-Nov-06 |
|
332 KB |
| 131 |
Draft G.S.R. 827(E) Dated 06.11.2019_Amendment of entry no. 23 of Schedule K of D & C Rules, 1945 |
2019-Nov-06 |
|
319 KB |
| 132 |
2019.10.18_G.S.R. 797(E)_Registration of Certain Medical Devices_chapter-IIIA |
2019-Oct-18 |
|
370 KB |
| 133 |
2019.10.16_S.O.3721 (E) Notification for Ultrasound equipment under 3b(iv) of D&C Act |
2019-Oct-16 |
|
270 KB |
| 134 |
2019.10.16_Final G.S.R 787(E) Exemption of State & Central Govt testing labs from NABL accreditation for two years under MDR 2017 |
2019-Oct-16 |
|
303 KB |
| 135 |
2019.09.13_Final G.S.R. 653(E)-Notification of ICD Dhannad Indore in MP for import of drugs under Rule 43A |
2019-Sep-13 |
|
242 KB |
| 136 |
2019.09.13_Final G.S.R.652(E)_Amendment in Form MD-10 to replace the SLA as issuing authority with CLA in MDR, 2017 |
2019-Sep-13 |
|
295 KB |
| 137 |
2019.08.08_Draft_GSR 567(E)_QR code for active pharmaceutical ingredients |
2019-Aug-13 |
|
321 KB |
| 138 |
Advisory on labeling requirements for combi kit of Misoprostol and Mifepristone tablets for Medical Termination of Pregnancy (MTP) |
2019-Aug-09 |
|
516 KB |
| 139 |
Publication of a Gazette Notification of Drugs Inspector in CDSCO under Section 21 of D&C Act, 1940 (23 of 1940) |
2019-Aug-02 |
|
386 KB |
| 140 |
2019.07.19 S.O. 2607_Prohibition of Colistin for food producing animals, poultry, aqua farming and animal feed supplements under Sec.26A |
2019-Jul-19 |
|
293 KB |
| 141 |
2019.07.17_Final G.S.R. 499 (E)Consesquential amendments to GSR 1337(E) Dt. 27.10.2017 |
2019-Jul-17 |
|
361 KB |
| 142 |
2019.06.24 Draft G.S.R. 447(E) Definition Responsibility labelling requirements for marketer of the drugs |
2019-Jun-24 |
|
332 KB |
| 143 |
2019.04.18 Final G.S.R. 318(E) Amendment in Rule 91 and Second Schedule for fees of free sale certificate in the MDR 2017 |
2019-Apr-18 |
|
310 KB |
| 144 |
2019.04.02 S.O. 1500(E) Notification of Organ Preservative solution as drug under Section 3(b)(iv) |
2019-Apr-02 |
|
286 KB |
| 145 |
G.S.R.227(E) 19 March 2019 |
2019-Mar-21 |
|
2458 KB |
| 146 |
2019.03.20 Final G.S.R. 231(E) Date of implementation of G.S.R.408(E) dated 26.04.2018 |
2019-Mar-20 |
|
305 KB |
| 147 |
New Drugs and Clinical Trials Rules 2019 G.S.R. 227(E) |
2019-Mar-20 |
|
3456 KB |
| 148 |
The New Drugs Clinical Trials Rules, 2019 |
2019-Mar-19 |
|
2458 KB |
| 149 |
2019.03.18 Final G.S.R.224(E) Amendment in Environmental requirements for mfg. of Medical Devices Annexure- A of the Fifth Schedule of MDR, 2017 |
2019-Mar-18 |
|
303 KB |
| 150 |
2019.03.18 Final G.S.R.223(E) Inclusion of Form 39A_Report of analysis by approved institution for individual or organization or procurement agency |
2019-Mar-18 |
|
345 KB |
| 151 |
2019.03.11 Final G.S.R.213(E) Notifcation of Chaudhary Charan Singh National Institute of Animal Health, UP for testing of Veterinary Vaccines |
2019-Mar-11 |
|
317 KB |
| 152 |
2019.03.11 Draft G.S.R. 214(E) Notification of ICD Dhannad Indore in Madhya Pradesh for import of drugs under Rule 43A |
2019-Mar-11 |
|
315 KB |
| 153 |
2019.03.08 Final G.S.R. 205(E) Omission of provision for writing brand name in brackets in Rule 96 of D &C Rules, 1945 |
2019-Mar-08 |
|
301 KB |
| 154 |
2019.03.06_Final G.S.R.186(E)_Hydroquinone included in Note to Schedule H of D & C Rules, 1945 |
2019-Mar-06 |
|
297 KB |
| 155 |
2019.03.06 Draft G.S.R.188(E) Amendment in Form MD-10 to replace the SLA as issuing authority with CLA in MDR, 2017 |
2019-Mar-06 |
|
314 KB |
| 156 |
2019.03.06_Draft G.S.R.187(E)_Amendment in Form 45 and Form 46 under Schedule-A of D&C Rules, 1945 |
2019-Mar-06 |
|
322 KB |
| 157 |
2019.02.26_Draft G.S.R.152(E)_Condition of licence for undertaking on brand or trade names of drugs |
2019-Feb-26 |
|
325 KB |
| 158 |
2019.02.26_Final G.S.R. 153(E)_Date of implementation for G.S.R. 277(E) dated 23.03.2018 |
2019-Feb-26 |
|
315 KB |
| 159 |
2019.02.08_S.O. 775(E)_ Notification of certain medical devices (8 no's) under definition of drug_Section 3(b)(iv) |
2019-Feb-08 |
|
265 KB |
| 160 |
2019.02.05_S.O. 697(E)_Revoke of FDC banned notification S.O. 4616(E) dated 07.09.2018_Section 26A |
2019-Feb-05 |
|
282 KB |
| 161 |
2019.02.04_Draft GSR 87(E)_Exqmption of State Central Govt testing labs from NABL accreditation for two years under MDR, 2017 |
2019-Feb-04 |
|
329 KB |
| 162 |
2019.02.04_Draft GSR 88(E)_Omission of provision for writing brand name in brackets in Rule 96 of D &C Rules, 1945 |
2019-Feb-04 |
|
312 KB |
| 163 |
25.01.2019_Final GSR 47(E)_Exemption of 100mL single use sterile parenteral solutions for export under Schedule K |
2019-Jan-25 |
|
346 KB |
| 164 |
2019.01.15_ Fina GSR 30(E)_Rule 3 Rule 59, 4th and 7th Schedules of MDR 2017 for insertion of e-IFU |
2019-Jan-15 |
|
314 KB |
| 165 |
2019.01.11_S.O. 180(E) to S.O.259(E)_Prohibition of certain FDCs appeared in the list of 294 FDCs, under Section 26A |
2019-Jan-11 |
|
1964 KB |
| 166 |
2019.01.10_Final GSR 19(E)_Provision for information to be uploaded by licensee on SUGAM portal |
2019-Jan-10 |
|
238 KB |
| 167 |
2019.01.10_Final GSR 20(E)__Notification of Mundra port and Kamarajar port under Rule 43A |
2019-Jan-10 |
|
292 KB |
| 168 |
018.12.13 S.O.6161(E) Restriction of Buclizine and its formulations as appetite stimulant under Section 26A |
2018-Dec-13 |
|
286 KB |
| 169 |
12018.12.12_Final_GSR 1193(E)_Fee Revision for registration and import license under D and C Rules, 1945 |
2018-Dec-12 |
|
312 KB |
| 170 |
2018.12.10_Draft_GSR 1190(E)_Date of implementation of G.S.R. 277(E) dated 23.03.2018 |
2018-Dec-10 |
|
290 KB |
| 171 |
2018.12.07_Draft_GSR 1185(E)_Date of implementation of GSR 408(E) dated 26.04.2018 |
2018-Dec-07 |
|
306 KB |
| 172 |
2018.12.07_ Final_GSR1186(E)_ Approved or permitted color in gelatine capsule Rule127(2) |
2018-Dec-07 |
|
306 KB |
| 173 |
2018.12.07_Draft_GSR 1187(E)_Amendment of Rule 91 and the Second Schedule for fees of free sale certificate in the MDR, 2017 |
2018-Dec-07 |
|
340 KB |
| 174 |
S.O.5980(E)-03-12-2018 |
2018-Dec-03 |
|
279 KB |
| 175 |
2018.12.03_ Final_GSR 1161(E)_Amendment in Rule 96 and Date of implemention of GSR 222(E) dated 13.03.2018 |
2018-Dec-03 |
|
308 KB |
| 176 |
2018.12.03_ S.O.5980_ Inclusion of four Medical devices in definition of drugs |
2018-Dec-03 |
|
279 KB |
| 177 |
S.O. 5980(E) dated 03.12.2018 |
2018-Dec-03 |
|
279 KB |
| 178 |
2018.11.29_Draft G.S.R. 1153(E)_Reg. Cosmetics Rules, 2018 |
2018-Nov-29 |
|
1276 KB |
| 179 |
2018.11.29_ Draft G.S.R. 1152(E)_Amendment in Part X B Part XII B pertains to Blood centre and Blood components |
2018-Nov-29 |
|
692 KB |
| 180 |
S.O. 1352(E) dated 23.03.2018_G.S.R. 1074(E) dated 30.10.2018 |
2018-Oct-30 |
|
445 KB |
| 181 |
2018 october 30 GSR 1074E Prohibition of import of Rapid Diagnostic Tests for MalariaSection 10A |
2018-Oct-30 |
|
399KB |
| 182 |
Notification of Mundra and Kamarajar Ports under Rule 43A, Draft GSR 1051(E) |
2018-Oct-25 |
|
304KB |
| 183 |
2018-10-05_Draft GSR 1000(E)_Fee Revision For Various Licensing Activities |
2018-Oct-05 |
|
1577 KB |
| 184 |
2018-10-05_Draft GSR 999(E)_Upgradation of Sch M GMP |
2018-Oct-05 |
|
4311 KB |
| 185 |
2018.09.25_S.O. 4972,4973 4974_Corrigendums to S.O. dated 07.09.2018 |
2018-Sep-25 |
|
1551 KB |
| 186 |
2018-09-25_Draft GSR 922(E)_Hydroquinone included in Note to Sch H |
2018-Sep-25 |
|
1660 KB |
| 187 |
2018-09-07_Draft GSR 848(E)_Rule 3, Rule 59, Fourth ScheduleSeventh Schedule of MDR 2017 |
2018-Sep-07 |
|
1712 KB |
| 188 |
2018.09.07_S.O. 4379(E) to S.O.4712 (E)_Prohibition and Restriction of FDC drugs_Section 26A |
2018-Sep-07 |
|
7414 KB |
| 189 |
2018.08.28_Draft GSR 817(E)_Sale of Drugs by E-Pharmacy |
2018-Aug-28 |
|
1896 KB |
| 190 |
2018-08-27_Draft GSR 813(E)_Amendment of Form 45 & 46 for Package Insert |
2018-Aug-27 |
|
1720 KB |
| 191 |
2018.08.21_Final GSR 794(E) and 795(E)_Mfg of Oxytocin Formulation Scheduling of Oxytocin in Sch H1 omittion from Sch H |
2018-Aug-21 |
|
1,709 KB |
| 192 |
2018.08.10_Draft GSR 763(E)_Inclusion of Oxytocin under Schedule H1 |
2018-Aug-10 |
|
1,785,856 KB |
| 193 |
G.S.R. 729 (E) dated 01.08.2018 |
2018-Aug-01 |
|
1742 KB |
| 194 |
2018.08.01_Final _GSR 729 (E) _Amendment of Performance evaluation report of in-vitro diagnostic medical devices |
2018-Aug-01 |
|
1,785,856 KB |
| 195 |
2018.07.30_Draft_GSR 721(E)_Amendment in Rule 127 reg. indication of colour in case of gelatine capsules |
2018-Jul-30 |
|
1,762 KB |
| 196 |
2018.07.30_Draft_GSR 720(E)_Inclusion of Form 39A_Report of test or analysis by approved institution |
2018-Jul-30 |
|
1,809 KB |
| 197 |
2018.07.30_Draft_GSR 719(E)_ Exemption of parenteral sterile solutions with 100 mL capacity for export by 100EOUs under Schedule K |
2018-Jul-30 |
|
1,755KB |
| 198 |
2018.07.19_Draft_GSR 660(E)_Amendment in Environmental requirements for mfg. of Medical Devices_Annexure- A of the Fifth Schedule of MDR, 2017 |
2018-Jul-19 |
|
1,806,336 KB |
| 199 |
2018.07.17_Draft_GSR 654(E)_Notifcation of Chaudhary Charan Singh National Institute of Animal Health, UP for testing of Veterinary Vaccines |
2018-Jul-17 |
|
1,794,048 KB |
| 200 |
2018.07.11_S.O.3400 (E)_ Notification of Medical Device Testing Officers (MDTO) |
2018-Jul-11 |
|
2,150,400 KB |
| 201 |
S.O. 3400(E) dated 11.07.2018 |
2018-Jul-11 |
|
2089 KB |
| 202 |
2018.07.11_Draft GSR 629 (E)Information to be uploaded on SUGAM by license |
2018-Jul-11 |
|
1,822,720 KB |
| 203 |
2018.07.03_Draft GSR 608E)_Perpetual Licensing |
2018-Jul-03 |
|
1,830,375 KB |
| 204 |
2018.06.29_GSR 602(E)_Extention of implementation date for GSR 411(E) dated 27.04.2018 |
2018-Jun-29 |
|
1,790,846 KB |
| 205 |
S.O. 2237(E) |
2018-Jun-01 |
|
1,752KB |
| 206 |
S.O. 2237(E) dated 01.06.2018 |
2018-Jun-01 |
|
1752 KB |
| 207 |
2018.05.15 Final S.O. 1929(E)_Reconstitution of DTAB 2018 |
2018-May-15 |
|
1,778KB |
| 208 |
Draft GSR 412 (E) Dt.27.04.2018_Reg. performance evaluation report of IVD medical devices |
2018-Apr-27 |
|
1,747KB |
| 209 |
GSR 411(E) dt 27.04.2018_Manufacture Prohibition of Oxytocin with conditions under Section 26A |
2018-Apr-27 |
|
1,745KB |
| 210 |
GSR 408 (E) dated 26.04.2018 Final amendment of Rule 96 Rule 97 Sch H Sch K |
2018-Apr-26 |
|
1,769KB |
| 211 |
GSR 390(E) dated 24.04.2018_Import banning of Oxytocin under Section 10A |
2018-Apr-24 |
|
1,721KB |
| 212 |
April 19th 2018 GSR 385(E) |
2018-Apr-19 |
|
1,780KB |
| 213 |
April 18th 2018 GSR 381(E) |
2018-Apr-18 |
|
1,763KB |
| 214 |
April 12th 2018 GSR 366(E) |
2018-Apr-12 |
|
1,740KB |
| 215 |
April 10th 2018 GSR 360(E) |
2018-Apr-10 |
|
1,730KB |
| 216 |
March 23rd 2018 GSR 277(E) |
2018-Mar-23 |
|
1,707KB |
| 217 |
March 23rd 2018 GSR 1352(E) |
2018-Mar-23 |
|
1,688KB |
| 218 |
F.No. Z-28015-2-2012-TB Dt.16.03.2018 Reg. Tuberculosis diagnosis and its management in patients |
2018-Mar-19 |
|
2,075KB |
| 219 |
March 13th 2018 GSR 222(E) |
2018-Mar-13 |
|
1,698KB |
| 220 |
2018.03.07_Final GSR 76_ Notification of Medical Device Officers (MDO) |
2018-Mar-07 |
|
1846 KB |
| 221 |
Extension of Expert Committee |
2018-Feb-09 |
|
667kb |
| 222 |
CTD Guidance Final |
2018-Feb-09 |
|
816kb |
| 223 |
List of PUSR meeting17 |
2018-Feb-09 |
|
7kb |
| 224 |
List of Bulk Drug Registered from 2007-july 2009 |
2018-Feb-09 |
|
202kb |
| 225 |
February 1st 2018 GSR 104(E) |
2018-Feb-01 |
|
3,859KB |
| 226 |
G.S.R 3609(E) |
2017-Nov-14 |
|
1,649KB |
| 227 |
November 10th 2017 GSR 1380(E) |
2017-Nov-10 |
|
1,645KB |
| 228 |
November 3rd 2017 GSR 1369(E) |
2017-Nov-03 |
|
1,667KB |
| 229 |
November 3rd 2017 GSR 1367(E) |
2017-Nov-03 |
|
1,595KB |
| 230 |
November 3rd 2017 GSR 1368(E) |
2017-Nov-03 |
|
1,585KB |
| 231 |
November 1st 2017 GSR 1357(E) |
2017-Nov-01 |
|
1,534KB |
| 232 |
October 27th 2017 GSR 1337(E) |
2017-Oct-27 |
|
1,625KB |
| 233 |
June 8th 2017 S.O 1851(E),1852 (E), 1853 (E),1854 (E), 1855(E) |
2017-Jun-08 |
|
1,217KB |
| 234 |
May 2nd 2017 GSR 429(E) |
2017-May-02 |
|
510KB |
| 235 |
April 13th 2017 GSR 367(E) |
2017-Apr-13 |
|
1,157KB |
| 236 |
April 3rd 2017 GSR 328(E) |
2017-Apr-03 |
|
299KB |
| 237 |
April 3rd 2017 GSR 327(E) |
2017-Apr-03 |
|
1,205KB |
| 238 |
April 3rd 2017 GSR 329(E) |
2017-Apr-03 |
|
1,202KB |
| 239 |
March 31 2017 GSR 319(E) |
2017-Mar-31 |
|
1,201KB |
| 240 |
March 30 2017 GSR 303(E) |
2017-Mar-30 |
|
1,149KB |
| 241 |
March 30 2017 GSR 302(E) |
2017-Mar-30 |
|
1,149KB |
| 242 |
March 15 2017 GSR 250(E) |
2017-Mar-15 |
|
1,156KB |
| 243 |
November 14th 2017 S.O 3609(E) |
2017-Feb-17 |
|
1649 KB |
| 244 |
24th October 2013 (GSR 703 (E) |
2017-Feb-17 |
|
558 KB |
| 245 |
27th August 2002 GSR 601 (E) |
2017-Feb-17 |
|
217 KB |
| 246 |
TB Sero Notification [IVD's |
2017-Feb-17 |
|
136 KB |
| 247 |
17th March 1989 GSR 365 (E) |
2017-Feb-17 |
|
166 KB |
| 248 |
6th October 2005 (SO 1468(E) |
2017-Feb-17 |
|
69 KB |
| 249 |
7th October 2005 (GSR 627 (E) |
2017-Feb-17 |
|
66 KB |
| 250 |
S.O. 2237(E)_Notification on Central Medical Device Testing Laboratory under MDR 2017 |
2017-Feb-17 |
|
1752 KB |
| 251 |
February 17 2017 GSR 144(E) |
2017-Feb-17 |
|
1,132KB |
| 252 |
February 17 2017 GSR 145(E) |
2017-Feb-17 |
|
1,131KB |
| 253 |
GSR 600 (E) Drugs [IVD's] |
2017-Feb-17 |
|
1336 KB |
| 254 |
May 19,2010(G.S.R_426 E) |
2017-Feb-17 |
|
681 KB |
| 255 |
February 2nd 2017 GSR 101(E) |
2017-Feb-02 |
|
1,116KB |
| 256 |
G.S.R. 103(E) dated 02.02.2017 |
2017-Feb-02 |
|
1121 KB |
| 257 |
February 2nd 2017 GSR 102(E) |
2017-Feb-02 |
|
1,120KB |
| 258 |
February 2nd 2017 GSR 103(E) |
2017-Feb-02 |
|
1,121KB |
| 259 |
February 1st 2017 GSR 80(E) |
2017-Feb-01 |
|
1,139KB |
| 260 |
January 31 2017 GSR 78(E) |
2017-Jan-31 |
|
3,029KB |
| 261 |
Medical Device Rule 2017 - GSR 78(E) Dated- 31.01.2017 |
2017-Jan-31 |
|
3029 KB |
| 262 |
January 31 2017 GSR 76(E) |
2017-Jan-31 |
|
1,125KB |
| 263 |
G.S.R. 78(E) dated 31.01.2017 |
2017-Jan-31 |
|
3029 KB |
| 264 |
January 19 2017 GSR 56(E) |
2017-Jan-19 |
|
1,107KB |
| 265 |
Mercury Limit-GSR56(E) |
2017-Jan-19 |
|
1,107kb |
| 266 |
January 17 2017 GSR 43(E) |
2017-Jan-17 |
|
1,106KB |
| 267 |
January 17 2017 GSR 44(E) |
2017-Jan-17 |
|
1,105KB |
| 268 |
January 17 2017 GSR 41(E) |
2017-Jan-17 |
|
1,136KB |
| 269 |
January 17 2017 GSR 42(E) |
2017-Jan-17 |
|
1,103KB |
| 270 |
January 16 2017 GSR 36(E) |
2017-Jan-16 |
|
1,102KB |
| 271 |
December 28 2016 GSR 1179(E) |
2016-Dec-28 |
|
227KB |
| 272 |
November 8 2016 GSR 1050(E) |
2016-Nov-08 |
|
968KB |
| 273 |
November 4 2016 GSR 1041(E) |
2016-Nov-04 |
|
962KB |
| 274 |
October 17 2016 GSR 983(E) |
2016-Oct-17 |
|
3,016KB |
| 275 |
September 21 2016 GSR 897(E) |
2016-Sep-21 |
|
240KB |
| 276 |
August 23 2016 GSR 812(E) |
2016-Aug-23 |
|
241KB |
| 277 |
August 12 2016 GSR790(E) |
2016-Aug-12 |
|
878KB |
| 278 |
August 4 2016 SO2612(E) |
2016-Aug-04 |
|
62KB |
| 279 |
June 29 2016 GSR 640(E) |
2016-Jun-29 |
|
484KB |
| 280 |
GSR 640 (E) dated 29.06.2016 regarding Schedule - MIII - Requirement of QMS for Medical Devices |
2016-Jun-17 |
|
484 KB |
| 281 |
2016.05.04_S.O. 1326(E)_Notification for Government Analyst_Dr. Raman Mohan Singh, Dir, CDTL, Mumbai |
2016-May-04 |
|
33 KB |
| 282 |
March 29 2016 GSR 357(E) |
2016-Mar-29 |
|
470KB |
| 283 |
March 16 2016 GSR 313(E) |
2016-Mar-16 |
|
131KB |
| 284 |
March 16 2016 GSR 312(E) |
2016-Mar-16 |
|
135KB |
| 285 |
March 10 2016 S.O 705(E) TO 1048(E) |
2016-Mar-10 |
|
2,744KB |
| 286 |
March 08 2016 GSR 287(E) |
2016-Mar-08 |
|
151KB |
| 287 |
March 01 2016 GSR 268(E) |
2016-Mar-01 |
|
127KB |
| 288 |
January 25,2016 S.O 237(E) |
2016-Jan-25 |
|
263KB |
| 289 |
January 06,2016 GSR 11(E) |
2016-Jan-06 |
|
150KB |
| 290 |
December 29, 2015 GSR 1011(E) |
2015-Dec-29 |
|
197KB |
| 291 |
November 30 2015 GSR 918(E) |
2015-Nov-30 |
|
124KB |
| 292 |
October 30 2015 GSR 826(E) |
2015-Oct-30 |
|
179KB |
| 293 |
August 20 2015 GSR 648(E) |
2015-Aug-20 |
|
276KB |
| 294 |
July 31 2015 GSR 611(E) |
2015-Jul-31 |
|
1,329KB |
| 295 |
July 17 2015 GSR 558(E) |
2015-Jul-17 |
|
155KB |
| 296 |
July 17 2015 GSR 559(E) |
2015-Jul-15 |
|
290KB |
| 297 |
June 16 2015 S.O 1597(E) |
2015-Jun-16 |
|
96KB |
| 298 |
June 3 2015 GSR 449(E) |
2015-Jun-03 |
|
1,337KB |
| 299 |
April 15 2015 GSR 289(E) |
2015-Apr-15 |
|
207KB |
| 300 |
March 30 2015 SO 873(E) |
2015-Mar-30 |
|
500KB |
| 301 |
Notification for different banks-GSR 873(E) |
2015-Mar-30 |
|
500kb |
| 302 |
March 25 2015 GSR 224(E) |
2015-Mar-25 |
|
639KB |
| 303 |
March 18 2015 GSR 203(E) |
2015-Mar-18 |
|
170KB |
| 304 |
Feb 17 2015 GSR 107(E) |
2015-Feb-17 |
|
131KB |
| 305 |
Feb 5 2015 GSR SO 375(E) |
2015-Feb-05 |
|
129KB |
| 306 |
Feb 5 2015 GSR 74(E) |
2015-Feb-05 |
|
154KB |
| 307 |
Feb 5 2015 GSR SO 376(E) |
2015-Feb-05 |
|
136KB |
| 308 |
Feb 3 2015 GSR 68(E) |
2015-Feb-03 |
|
224KB |
| 309 |
Feb 3 2015 GSR 69(E) |
2015-Feb-03 |
|
232KB |
| 310 |
Jan 16 2015 GSR 38(E) |
2015-Jan-16 |
|
882KB |
| 311 |
Dec 29 2014 SO 3298(E) |
2014-Dec-29 |
|
144KB |
| 312 |
Dec 22 2014 GSR 908(E) |
2014-Dec-22 |
|
138KB |
| 313 |
G.S.R. 908 (E) dated 22.12.2014 |
2014-Dec-22 |
|
138 KB |
| 314 |
Dec 12 2014 GSR 889(E) |
2014-Dec-12 |
|
452KB |
| 315 |
S.O.2617(E)_2014.10.13 Notification of Drugs Inspector |
2014-Oct-13 |
|
179 KB |
| 316 |
Sep 29 2014 GSR 701(E) |
2014-Sep-29 |
|
175KB |
| 317 |
Sep 25 2014 GSR 690(E) |
2014-Sep-25 |
|
222KB |
| 318 |
G.S.R 690(E) |
2014-Sep-25 |
|
222kb |
| 319 |
Sep 02 2014 GSR 633(E) |
2014-Sep-02 |
|
111KB |
| 320 |
Aug 07 2014 GSR 570(E) |
2014-Aug-07 |
|
180KB |
| 321 |
July 14 2014 GSR 502(E) |
2014-Jul-14 |
|
78KB |
| 322 |
July 14 2014 GSR 503(E) |
2014-Jul-14 |
|
84KB |
| 323 |
July 11.2014 GSR 498(E) |
2014-Jul-11 |
|
82KB |
| 324 |
May 23 2014 G.S.R 350(E) |
2014-May-23 |
|
98KB |
| 325 |
Animal Testing Ban-GSR 346(E) |
2014-May-21 |
|
922kb |
| 326 |
May 21 2014 G.S.R 346(E) |
2014-May-21 |
|
922KB |
| 327 |
May 5.2014 G.S.R. 310(E) |
2014-May-05 |
|
792KB |
| 328 |
May 5 2014 G.S.R 311(E) |
2014-May-05 |
|
871KB |
| 329 |
May 5.2014 G.S.R.312(E) |
2014-May-05 |
|
1,097KB |
| 330 |
April 24.04.2014 G.S.R 292 (E) |
2014-Apr-24 |
|
116KB |
| 331 |
Import Animal Testing Ban-G.S.R.718(E) |
2014-Mar-13 |
|
168kb |
| 332 |
March 11.03.2014 G.S.R 176 (E) |
2014-Mar-11 |
|
96KB |
| 333 |
February 13.02.2014 G.S.R 86 (E) |
2014-Feb-13 |
|
510KB |
| 334 |
Jan 17.01.2014 G.S.R. 29 (E) |
2014-Jan-17 |
|
432KB |
| 335 |
Dec 23.12.2013 GSR 3793(E) |
2013-Dec-23 |
|
135KB |
| 336 |
S.G 3793(E) |
2013-Dec-23 |
|
135kb |
| 337 |
Nov 07.11.2013 GSR 724(E) |
2013-Nov-07 |
|
717KB |
| 338 |
2013.11.07_S.O. 3395(E)_Notification for Appointment of Drugs Inspectors |
2013-Nov-07 |
|
213 KB |
| 339 |
Nov24.11.2013 GSR 702 (E) |
2013-Oct-24 |
|
3,688KB |
| 340 |
October 24.10.2013 GSR 703(E) |
2013-Oct-24 |
|
693KB |
| 341 |
August 30.08.2013 GSR 588 (E) |
2013-Aug-30 |
|
180KB |
| 342 |
August 30.08.2013 GSR 590(E) |
2013-Aug-30 |
|
55KB |
| 343 |
August 30.08.2013 GSR 589 (E) |
2013-Aug-30 |
|
73KB |
| 344 |
July 31.07.2013 GSR 520(E) |
2013-Jul-31 |
|
1,948KB |
| 345 |
June 18.06.2013 G.S.R 377(E) |
2013-Jun-18 |
|
428KB |
| 346 |
June 18.06.2013 G.S.R 378(E) |
2013-Jun-18 |
|
363KB |
| 347 |
June 18.06.2013 G.S.R 379(E) |
2013-Jun-18 |
|
250KB |
| 348 |
June 07.06.2013 G.S.R 364 (E) |
2013-Jun-07 |
|
494KB |
| 349 |
May 23.05.2013 (GSR 332(E) |
2013-May-23 |
|
265KB |
| 350 |
Feb 08.02.2013 (GSR 72(E) |
2013-Feb-08 |
|
4,257KB |
| 351 |
Feb 01.02.2013 (GSR 63 E) |
2013-Feb-01 |
|
1,256KB |
| 352 |
January 30.01.2013 (GSR 53 E) |
2013-Jan-30 |
|
596KB |
| 353 |
January 24.01.2013 (GSR 43E) |
2013-Jan-24 |
|
2,745KB |
| 354 |
2012.11.30_S.O. 2810(E)_Notification of GA of CDL Kolkata |
2012-Nov-30 |
|
32 KB |
| 355 |
2012.11.30_ S.O. 2808 (E) GA notification at CDTL Mumbai |
2012-Nov-30 |
|
41 KB |
| 356 |
November 08,2012 ( G.S.R 816 (E) ) |
2012-Nov-08 |
|
1,003KB |
| 357 |
2012.10.19_S.O. 2527(E)_Notification of Subrat Kumar CDL kolkata |
2012-Oct-19 |
|
38 KB |
| 358 |
Octboer 05.10.2012(G.S.R 748(E)) |
2012-Oct-05 |
|
284KB |
| 359 |
September 29,2012 (G.S.R. 733(E)) |
2012-Sep-29 |
|
284KB |
| 360 |
July 17, 2012 (GSR 575(E)) |
2012-Jul-17 |
|
828KB |
| 361 |
July 17, 2012 (GSR 574(E)) |
2012-Jul-17 |
|
1,787KB |
| 362 |
July 17, 2012 (GSR 573(E)) |
2012-Jul-17 |
|
2,939KB |
| 363 |
July 17, 2012 (GSR 572(E) |
2012-Jul-17 |
|
1,446KB |
| 364 |
GSR 433 (E) dated 7.June 2012 |
2012-Jun-07 |
|
136 KB |
| 365 |
March 30, 2012 (GSR 270(E) |
2012-Mar-30 |
|
254KB |
| 366 |
2012.03.29_S.O. 652(E)_Dr. M.F.A. Beg, SSO, CDL, Kolkata_Signing Authority_COA |
2012-Mar-29 |
|
44 KB |
| 367 |
March 20, 2012 (GSR 228(E)) |
2012-Mar-20 |
|
1,293KB |
| 368 |
January 17,2012 (GSR 28(E) |
2012-Jan-17 |
|
51KB |
| 369 |
December 27, 2011 (GSR 899(E) |
2011-Dec-27 |
|
7,384KB |
| 370 |
Nov 18, 2011 (GSR 821(E)) |
2011-Nov-18 |
|
1,160KB |
| 371 |
November 3, 2011 ( S.O. 2496(E) |
2011-Nov-03 |
|
175KB |
| 372 |
October 12, 2011 (GSR 752 (E)) |
2011-Oct-12 |
|
78KB |
| 373 |
Sept 29, 2011 (GSR 733(E)) |
2011-Sep-29 |
|
70KB |
| 374 |
July 21, 2011, (GSR 557 (E) |
2011-Jul-21 |
|
688KB |
| 375 |
June 2, 2011, (GSR 425 (E) |
2011-Jun-02 |
|
127KB |
| 376 |
May 30, 2011 (GSR 418 (E) |
2011-May-30 |
|
149KB |
| 377 |
April 8, 2011 (S.O 722 (E) |
2011-Apr-08 |
|
196KB |
| 378 |
Notification - Extension of Import registration - Gazette notification G.S.R. 263(E), Mar 30, 2011 |
2011-Mar-30 |
|
66KB |
| 379 |
Notification, Mar 16, 2011 (G.S.R. 218 (E) |
2011-Mar-16 |
|
75KB |
| 380 |
Notification, Feb 18, 2011 (G.S.R.101(E)) |
2011-Feb-18 |
|
1,802KB |
| 381 |
Drugs Prohibited vide Gazette notification, Feb 10, 2011 (G.S.R.82(E)) |
2011-Feb-10 |
|
84KB |
| 382 |
Jan 24, 2011 (G.S.R 45 (E)) |
2011-Jan-24 |
|
123KB |
| 383 |
Jan 19, 2011 (G.S.R 40 (E)) |
2011-Jan-19 |
|
566KB |
| 384 |
Nov 12, 2010 (G.S.R 910E) |
2010-Nov-12 |
|
79KB |
| 385 |
Registration for Import of cosmetics-GSR 426(E) |
2010-May-19 |
|
9,488kb |
| 386 |
April 9,2010(G.S.R_303 E) |
2010-Apr-09 |
|
1,717KB |
| 387 |
Jan21,2010(G.S.R_45(E) |
2010-Jan-21 |
|
996KB |
| 388 |
Dec22,2009(G.S.R_917(E) |
2009-Dec-22 |
|
1,369KB |
| 389 |
Dec_11,2009(G.S.R_884(E) |
2009-Dec-11 |
|
824KB |
| 390 |
Dec_11,2009(G.S.R_885(E) |
2009-Dec-11 |
|
1,395KB |
| 391 |
Nov_14,2009(S.O.3077) |
2009-Nov-14 |
|
461KB |
| 392 |
Oct_29,2009(G.S.R_790(E) |
2009-Oct-29 |
|
1,248KB |
| 393 |
Sept 15,2009(G.S.R 677 E) |
2009-Sep-15 |
|
1,314KB |
| 394 |
Sept_9,2009(G.S.R_651(E) |
2009-Sep-09 |
|
1,380KB |
| 395 |
Aug_28,2009(G.S.R_607(E) |
2009-Aug-28 |
|
827KB |
| 396 |
June 16,2009 (G.S.R.355) |
2009-Jun-16 |
|
451KB |
| 397 |
June 16, 2009 (G.S.R.354) |
2009-Jun-16 |
|
7,668KB |
| 398 |
G.S.R 45(E) dated 22.01.2009 Drugs and Cosmetics First Amendment Rules 2009 |
2009-Jan-22 |
|
68 KB |
| 399 |
G.S.R 46(E) dated 22.01.2009 Drugs and Cosmetics First Amendment Rules 2009 |
2009-Jan-22 |
|
87 KB |
| 400 |
July 5,2008 (G.S.R 364) |
2008-Jul-05 |
|
478KB |
| 401 |
April 16,2008 (G.S.R.207) |
2008-Apr-16 |
|
1,271KB |
| 402 |
2nd February 2007(G.S.R 62(E)) |
2007-Feb-02 |
|
316KB |
| 403 |
2nd February 2007 (G.S.R. 63(E)) |
2007-Feb-02 |
|
362KB |
| 404 |
16th March 2006(GSR 160 (E)) |
2006-Mar-16 |
|
742KB |
| 405 |
G.S.R 627(E) |
2005-Oct-07 |
|
66kb |
| 406 |
7th Oct 2005(GSR 627 (E)) |
2005-Oct-07 |
|
66KB |
| 407 |
6th Oct 2005(SO 1468 (E) regarding sterile devices intended for exteranl or internal use in human beings as drugs |
2005-Oct-06 |
|
69 KB |
| 408 |
S.O 1468(E) |
2005-Oct-06 |
|
69kb |
| 409 |
28th July 2005(GSR 510 (E)) |
2005-Jul-28 |
|
57KB |
| 410 |
30th June 2005(GSR 431 (E)) |
2005-Jun-30 |
|
473KB |
| 411 |
GSR_601_E_27-08-2002 |
2002-Aug-27 |
|
1336 KB |
| 412 |
G.S.R. 600(E) |
2002-Aug-07 |
|
1336kb |
| 413 |
1st May 2002 (GSR 311(E)) |
2002-May-01 |
|
129KB |
| 414 |
G.S.R. 365(E) |
1989-Jun-17 |
|
166kb |
